Lindus Health Achieves Recognition for Innovation in Clinical Trials
Lindus Health, a pioneering anti-CRO, has been honored as the winner in the Outstanding Patient Recruitment and Retention category of the prestigious 2025 Fierce CRO Awards. This accolade highlights exceptional advancements by Contract Research Organizations (CROs) in enhancing clinical research and improving patient outcomes.
Transformative Approaches to Patient Recruitment
The award underscores Lindus Health's commitment to running clinical trials with greater efficiency and reliability. By employing the Patient Identification Center (PIC) technique, the company leverages advanced algorithms and customized search protocols derived from real-world medical records. This innovative method not only reduces screen failure rates but also accelerates patient recruitment with remarkable precision.
Success in Clinical Trials
One prominent example of Lindus Health's success is their collaboration with Myota on a pre-diabetes trial. Utilizing the PIC approach, they achieved an impressive 54% screening conversion rate—significantly surpassing the industry benchmark—and completed the trial enrollment in just four months. This achievement showcases the effectiveness of their strategies in navigating the complexities of clinical research.
A Patient-Centric Focus
Lindus Health differentiates itself in the industry by executing highly customized participant searches. Rather than relying solely on standard queries conducted by medical practices, the firm creates in-house searches tailored to capture the nuances of data recording by general practitioners. For instance, when recruiting for a trial focused on patients with "reduced sexual desire," Lindus optimized their search by using terms like "low libido," improving their ability to identify eligible candidates.
Statement from Leadership
“Receiving the Fierce CRO Award is a tremendous honor,” expressed Meri Beckwith, co-founder of Lindus Health. “It reflects our mission to address the shortcomings of the clinical trial model, allowing patients faster access to new treatments. Through innovative strategies like our PIC technique, smart study design, and proprietary AI, we deliver trials that are not only faster but also more precise and cost-effective.”
Continuous Innovation and Growth
This recognition follows Lindus Health's successful Series B funding round, which raised $55 million to enhance their clinical operations and further develop their AI-powered eClinical platform, Citrus™. This funding supports improvements in study design, central monitoring, and real-time biostatistics. Having a fully in-house platform, Lindus integrates essential clinical research technologies, uniting systems like CTMS, EDC, visit scheduling, and more into a streamlined ecosystem.
Collaborative Efforts and Research Contributions
In addition to their operational advancements, Lindus Health is collaborating with institutions like Oxford University to publish research on diverse perceptions of clinical trial participation. Such initiatives aim to foster more inclusive and patient-centered approaches in clinical research. Furthermore, they are working with CDISC to establish standardized templates for clinical observations and contributing to innovative programs that elevate trial design safety through AI utilization.
Looking Ahead: Lindus Health's Vision
As Lindus Health continues to push the boundaries of what is possible in clinical research, the focus remains on enhancing the experience for patients while ensuring that treatments are accessible. The journey to refine clinical trials is ongoing, and the company is committed to making research increasingly efficient, inclusive, and rooted in patient needs.
About Lindus Health
Lindus Health is an anti-CRO dedicated to streamlining clinical trials, providing quicker access to groundbreaking treatments for patients. Their innovative business model aligns incentives through fixed pricing per study with milestone payments. The company's world-class clinical operations team utilizes a unique software platform and has access to over 40 million Electronic Health Records to drive success.
Clinical trials often pose significant barriers to healthcare advancements. Lindus Health seeks to eliminate these constraints through comprehensive execution of studies, leveraging technology and innovative approaches to clinical operations.
To date, Lindus Health's clinical trials have spanned various conditions including diabetes, asthma, and major depressive disorder, among others. The firm has successfully raised over $80 million from notable investors, including Peter Thiel, Balderton, and Creandum.
Frequently Asked Questions
What is the significance of the Fierce CRO Award?
The Fierce CRO Award recognizes outstanding achievements by Contract Research Organizations, celebrating their innovations and contributions to clinical research.
How does Lindus Health enhance patient recruitment?
Lindus Health employs the Patient Identification Center technique, utilizing advanced algorithms and customized searches to optimize patient recruitment processes.
What recent advancements has Lindus Health made?
Recently, Lindus Health raised $55 million in Series B funding to expand their capabilities, including advancements in their AI-powered eClinical platform.
What types of clinical trials does Lindus Health conduct?
Lindus Health conducts clinical trials across various conditions, focusing on areas like diabetes, asthma, and depression, leveraging their unique methodologies.
How does Lindus Health ensure a patient-centric approach?
By customizing participant searches and optimizing terminology for better data identification, Lindus Health aims to enhance inclusivity and representativeness in clinical trials.
